These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30265680)

  • 1. Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature.
    Hoffman LK; Tomalin LE; Schultz G; Howell MD; Anandasabapathy N; Alavi A; Suárez-Fariñas M; Lowes MA
    PLoS One; 2018; 13(9):e0203672. PubMed ID: 30265680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin.
    Coates M; Mariottoni P; Corcoran DL; Kirshner HF; Jaleel T; Brown DA; Brooks SR; Murray J; Morasso MI; MacLeod AS
    PLoS One; 2019; 14(5):e0216249. PubMed ID: 31059533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome patterns in hidradenitis suppurativa: support for the role of antimicrobial peptides and interferon pathways in disease pathogenesis.
    Shanmugam VK; Jones D; McNish S; Bendall ML; Crandall KA
    Clin Exp Dermatol; 2019 Dec; 44(8):882-892. PubMed ID: 30828847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. B-cell and complement signature in severe hidradenitis suppurativa that does not respond to adalimumab.
    Hambly R; Gatault S; Smith CM; Iglesias-Martinez LF; Kearns S; Rea H; Marasigan V; Lynam-Loane K; Kirthi S; Hughes R; Fletcher JM; Kolch W; Kirby B
    Br J Dermatol; 2023 Jan; 188(1):52-63. PubMed ID: 36689500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inflammatory proteome of hidradenitis suppurativa skin is more expansive than that of psoriasis vulgaris.
    Navrazhina K; Garcet S; Frew JW; Zheng X; Coats I; Guttman-Yassky E; Krueger JG
    J Am Acad Dermatol; 2022 Feb; 86(2):322-330. PubMed ID: 34339761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of miRNA-155, miRNA-223, miRNA-31, miRNA-21, miRNA-125b, and miRNA-146a in the Inflammatory Pathway of Hidradenitis Suppurativa.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    Inflammation; 2017 Apr; 40(2):464-472. PubMed ID: 28028756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in innate immunity and epithelial cell differentiation are the molecular pillars of hidradenitis suppurativa.
    Zouboulis CC; Nogueira da Costa A; Makrantonaki E; Hou XX; Almansouri D; Dudley JT; Edwards H; Readhead B; Balthasar O; Jemec GBE; Bonitsis NG; Nikolakis G; Trebing D; Zouboulis KC; Hossini AM
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):846-861. PubMed ID: 31838778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Hidradenitis Suppurativa molecular disease signature derived from patient samples by high-throughput RNA sequencing and re-analysis of previously reported transcriptomic data sets.
    Freudenberg JM; Liu Z; Singh J; Thomas E; Traini C; Rajpal DK; Sayed CJ
    PLoS One; 2023; 18(4):e0284047. PubMed ID: 37023004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitinase-3-like Protein 1 (YKL-40) Is Expressed in Lesional Skin in Hidradenitis Suppurativa.
    Salomon J; Piotrowska A; Matusiak Ł; Dzięgiel P; Szepietowski JC
    In Vivo; 2019; 33(1):141-143. PubMed ID: 30587614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of native, activated Notch receptors in normal human apocrine-bearing skin and in hidradenitis suppurativa.
    Stabell SH; Renzi A; Nilsen HR; Antonsen OH; Fosse JH; Haraldsen G; Sundnes O
    Exp Dermatol; 2024 Jan; 33(1):e14977. PubMed ID: 38060347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model.
    Vossen ARJV; van der Zee HH; Prens EP
    Front Immunol; 2018; 9():2965. PubMed ID: 30619323
    [No Abstract]   [Full Text] [Related]  

  • 12. Inflammation induced changes in the expression levels of components of the microRNA maturation machinery Drosha, Dicer, Drosha co-factor DGRC8 and Exportin-5 in inflammatory lesions of hidradenitis suppurativa patients.
    Hessam S; Sand M; Skrygan M; Gambichler T; Bechara FG
    J Dermatol Sci; 2016 Jun; 82(3):166-74. PubMed ID: 26917346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Concentration and Skin Expression of S100A7 (Psoriasin) in Patients Suffering from Hidradenitis Suppurativa.
    Batycka-Baran A; Baran W; Nowicka-Suszko D; Koziol-Gałczyńska M; Bieniek A; Matusiak Ł; Łaczmański Ł; Szepietowski JC
    Dermatology; 2021; 237(5):733-739. PubMed ID: 33202403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions.
    Hessam S; Gambichler T; Skrygan M; Sand M; Rüddel I; Scholl L; Bechara FG
    Eur J Dermatol; 2018 Aug; 28(4):449-456. PubMed ID: 30325321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis.
    Gudjonsson JE; Tsoi LC; Ma F; Billi AC; van Straalen KR; Vossen ARJV; van der Zee HH; Harms PW; Wasikowski R; Yee CM; Rizvi SM; Xing X; Xing E; Plazyo O; Zeng C; Patrick MT; Lowe MM; Burney RE; Kozlow JH; Cherry-Bukowiec JR; Jiang Y; Kirma J; Weidinger S; Cushing KC; Rosenblum MD; Berthier C; MacLeod AS; Voorhees JJ; Wen F; Kahlenberg JM; Maverakis E; Modlin RL; Prens EP
    JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32853177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary alterations during the development of hidradenitis suppurativa.
    Dajnoki Z; Somogyi O; Medgyesi B; Jenei A; Szabó L; Gáspár K; Hendrik Z; Gergely P; Imre D; Póliska S; Törőcsik D; Zouboulis CC; Prens EP; Kapitány A; Szegedi A
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):462-471. PubMed ID: 34724272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microRNA effector RNA-induced silencing complex in hidradenitis suppurativa: a significant dysregulation within active inflammatory lesions.
    Hessam S; Sand M; Skrygan M; Bechara FG
    Arch Dermatol Res; 2017 Sep; 309(7):557-565. PubMed ID: 28634830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
    Dany M; Elston D
    J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Disease-Associated Pathways in Hidradenitis Suppurativa by the Janus Kinase 1 Inhibitor Povorcitinib: Transcriptomic and Proteomic Analyses of Two Phase 2 Studies.
    Liu H; Santos LL; Smith SH
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrated Approach to Unravel Hidradenitis Suppurativa Etiopathogenesis.
    Tricarico PM; Boniotto M; Genovese G; Zouboulis CC; Marzano AV; Crovella S
    Front Immunol; 2019; 10():892. PubMed ID: 31105704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.